NZ514883A - Anti-bacterial vaccine compositions - Google Patents

Anti-bacterial vaccine compositions

Info

Publication number
NZ514883A
NZ514883A NZ514883A NZ51488300A NZ514883A NZ 514883 A NZ514883 A NZ 514883A NZ 514883 A NZ514883 A NZ 514883A NZ 51488300 A NZ51488300 A NZ 51488300A NZ 514883 A NZ514883 A NZ 514883A
Authority
NZ
New Zealand
Prior art keywords
atpg
gene
decreased
biological activity
activity
Prior art date
Application number
NZ514883A
Other languages
English (en)
Inventor
David E Lowery
Troy E Fuller
Michael J Kennedy
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NZ514883A publication Critical patent/NZ514883A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ514883A 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions NZ514883A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12868999P 1999-04-09 1999-04-09
US15345399P 1999-09-10 1999-09-10
PCT/US2000/009218 WO2000061724A2 (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions

Publications (1)

Publication Number Publication Date
NZ514883A true NZ514883A (en) 2004-03-26

Family

ID=26826843

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ530012A NZ530012A (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions
NZ514883A NZ514883A (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ530012A NZ530012A (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions

Country Status (14)

Country Link
US (5) US20070237793A1 (OSRAM)
EP (5) EP2281835B1 (OSRAM)
JP (4) JP4892134B2 (OSRAM)
KR (4) KR20010112937A (OSRAM)
CN (1) CN1351653A (OSRAM)
AR (1) AR029622A1 (OSRAM)
AU (2) AU780887B2 (OSRAM)
BR (1) BR0009663A (OSRAM)
CA (1) CA2366520C (OSRAM)
ES (2) ES2535961T3 (OSRAM)
HK (1) HK1045856A1 (OSRAM)
MX (1) MXPA01010207A (OSRAM)
NZ (2) NZ530012A (OSRAM)
WO (1) WO2000061724A2 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010112937A (ko) * 1999-04-09 2001-12-22 로렌스 티. 마이젠헬더 항균성 백신 조성물
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
EP1449924B1 (en) * 2001-09-26 2008-12-24 Kyowa Hakko Kogyo Co., Ltd. Process for producing galactose-containing complex sugar
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
ATE470674T1 (de) * 2002-04-05 2010-06-15 Merial Sas Abgeschwächte gramnegative bakterien
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
EP1602720B1 (en) * 2003-03-05 2010-11-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing heterologous protein in e. coli
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
WO2008045238A2 (en) * 2006-10-05 2008-04-17 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
JP2011522796A (ja) 2008-05-06 2011-08-04 ニューヨーク ブラッド センター， インコーポレイテッド 抗ウイルス細胞透過性ペプチド
DE102011016772B8 (de) * 2011-04-12 2024-08-14 Mercedes-Benz Group AG Verfahren und Vorrichtung zur Überwachung zumindest eines Fahrzeuginsassen und Verfahren zum Betrieb zumindest einer Assistenzvorrichtung
EP3062816B1 (en) 2013-11-01 2020-08-05 Boehringer Ingelheim Animal Health USA Inc. Attenuated pasteurella multocida vaccines & methods of making & use thereof
MX2019009409A (es) * 2017-02-10 2019-09-27 Epitopix Llc Proteinas y composiciones de inmunizacion que contienen proteinas de pasteurella y metodos de uso.
TW202219269A (zh) 2020-09-30 2022-05-16 美國農業部 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗
TW202214294A (zh) 2020-09-30 2022-04-16 美商碩騰服務公司 具有ｈｙａＣ及ｎａｎＰ缺失之新穎多殺性巴斯德氏菌株及疫苗
CN113567415A (zh) * 2021-07-05 2021-10-29 广西大学 表面增强拉曼散射结合免疫层析技术检测布鲁氏杆菌方法
CN115925536B (zh) * 2022-08-01 2025-02-28 北京农学院 靶向抑制DksA的小分子抑制剂和应用
CN116593695B (zh) * 2022-12-29 2025-08-05 重庆澳龙生物制品有限公司 一种牛多杀性巴氏杆菌荚膜a型elisa抗体检测试剂盒及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
DE3426532A1 (de) 1984-07-18 1986-01-30 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verwendung einer dna-sequenz zur expression sowie dna-struktur und expressionsvektor mit der dna-sequenz
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
ATE71303T1 (de) 1986-01-14 1992-01-15 Nederlanden Staat Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
DK46693D0 (OSRAM) * 1993-04-23 1993-04-23 Novo Nordisk As
CA2099841C (en) * 1991-03-05 2003-02-25 Ian G. Charles Expression of recombinant proteins in attenuated bacteria
US5840312A (en) * 1991-05-02 1998-11-24 Institut Pasteur Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
CA2148829A1 (en) * 1992-11-06 1994-05-26 Keum Hwa Choi Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
DE19502584C2 (de) 1994-01-28 1999-08-12 Medigene Ag Ges Fuer Molekular Verfahren zur Bestimmung der Aktivität eines regulatorischen Faktors sowie Verwendung dieses Verfahrens
US5888783A (en) 1994-08-30 1999-03-30 Ajinomoto Co., Inc. Methods for producing L-valine and L-leucine
EP1285960A3 (en) 1994-12-09 2003-05-07 Imperial College Innovations Limited Virulence genes from Salmonella typhimurium
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
US6355450B1 (en) 1995-04-21 2002-03-12 Human Genome Sciences, Inc. Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
US5994066A (en) 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US5840556A (en) * 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
CA2206575A1 (en) * 1996-05-31 1997-11-30 Akzo Nobel Nv Live attenuated rtx-producing bacteria of the family pasteurellaceae
US6020474A (en) 1997-01-15 2000-02-01 Incyte Pharmaceuticals, Inc. ATP synthase subunits
US6673538B1 (en) 1997-07-25 2004-01-06 The Trustees Of Boston University Methods and compositions for designing vaccines
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
KR20010112937A (ko) * 1999-04-09 2001-12-22 로렌스 티. 마이젠헬더 항균성 백신 조성물
WO2000078922A2 (en) 1999-06-21 2000-12-28 North Carolina State University Acid-inducible promoters for gene expression
US6376211B1 (en) 1999-07-12 2002-04-23 Xoma Technology Ltd. Agents and methods for inhibiting F1/F0 ATPase

Also Published As

Publication number Publication date
US7763262B2 (en) 2010-07-27
JP5973634B2 (ja) 2016-08-23
ES2439645T3 (es) 2014-01-24
KR20010112937A (ko) 2001-12-22
US20120148625A1 (en) 2012-06-14
JP5377433B2 (ja) 2013-12-25
EP2281833A2 (en) 2011-02-09
MXPA01010207A (es) 2003-07-21
EP2281834B1 (en) 2015-03-04
JP4892134B2 (ja) 2012-03-07
AU2005203189B2 (en) 2007-12-20
US20100322975A1 (en) 2010-12-23
CN1351653A (zh) 2002-05-29
WO2000061724A2 (en) 2000-10-19
US20070237793A1 (en) 2007-10-11
EP2281834A3 (en) 2011-11-23
JP2002541790A (ja) 2002-12-10
EP1860117A2 (en) 2007-11-28
KR20060116041A (ko) 2006-11-13
CA2366520A1 (en) 2000-10-19
ES2535961T3 (es) 2015-05-19
JP2016019528A (ja) 2016-02-04
CA2366520C (en) 2013-10-01
EP2281835A3 (en) 2011-11-23
KR20070011622A (ko) 2007-01-24
AR029622A1 (es) 2003-07-10
NZ530012A (en) 2005-10-28
US8974798B2 (en) 2015-03-10
EP2281833A3 (en) 2011-11-30
US20090202594A1 (en) 2009-08-13
US20150182615A1 (en) 2015-07-02
HK1045856A1 (zh) 2002-12-13
EP1860117A3 (en) 2008-09-03
JP2013121347A (ja) 2013-06-20
WO2000061724A3 (en) 2001-02-01
AU780887B2 (en) 2005-04-21
AU2005203189A1 (en) 2005-08-18
BR0009663A (pt) 2002-04-09
KR20060134225A (ko) 2006-12-27
AU4077600A (en) 2000-11-14
JP2010284165A (ja) 2010-12-24
US9289486B2 (en) 2016-03-22
EP2281835B1 (en) 2013-11-06
EP2281834A2 (en) 2011-02-09
EP1171577A2 (en) 2002-01-16
EP2281835A2 (en) 2011-02-09
EP2281833B1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
NZ514883A (en) Anti-bacterial vaccine compositions
Assih et al. Stenotrophomonas acidaminiphila sp. nov., a strictly aerobic bacterium isolated from an upflow anaerobic sludge blanket (UASB) reactor.
Young et al. A bifunctional urease enhances survival of pathogenic Yersinia enterocolitica and Morganella morganii at low pH
Marshall et al. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms
Meyer et al. Evidence against use of bacterial amino acid sequence data for construction of all-inclusive phylogenetic trees.
Archer et al. Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus
SG165157A1 (en) Identification of genes
EP1167542A3 (en) Probe for diagnosing infectious disease arising from Enterococcus faecalis
WO1999033960A3 (en) Proteases from gram positive organisms
WO1999034003A3 (en) Proteases from gram positive organisms
KR20060121212A (ko) 세린 프로테아제, 세린 효소들을 인코딩하는 핵산 및 이를편입시킨 벡터 및 숙주 세포
AR035745A1 (es) Bacteria gram-negativa, una composicion inmunogena, una composicion para vacunas, un metodo para producir un mutante, un polinucleotido de pasteurellaceae purificado y aislado, un vector, una celula transformada establemente o transfectada, metodo para producir un polipeptido recombinante, anticuerp
MacKinnon et al. Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain
AU2003223447A1 (en) Attenuated gram negative bacteria
EP1108786A4 (en) NEW COLLECTIN
EP1047710B1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
Robinson et al. X chromosome evolution in the suni and eland antelope: detection of homologous regions by fluorescence in situ hybridization and G-banding
EP1164190A4 (en) RHEUMATIC ARTHRITIS GENE AND METHOD FOR THE DIAGNOSIS OF RHEUMATIC ARTHRITIS
PT1350796E (pt) Bactérias gram-negativas atenuadas
JP3961306B2 (ja) 黒麹菌のフェリクローム生合成に関与するクラスター遺伝子
ATE318933T1 (de) Nukleinsäurefragmente zur identifizierung von dechlorierenden bakterien
GB9724627D0 (en) Gram positive microorganism formate pathway
GB9321302D0 (en) Enzyme
TW200700555A (en) Saponin-decomposing enzyme, gene thereof and large-scale production system for producing soyasapogenol b
AU710730B2 (en) Method to predict active growth of bacteria adhered to a surface

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)